Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: The Pharmaceutical Press, 1996.

Wichtl MW. Herbal Drugs and Phytopharmaceuticals. Ed. N.M. Bisset. Stuttgart: Medpharm GmbH Scientific Publishers, 1994.

Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.

Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182

Hasanudin K, Hashim P, Mustafa S. Corn silk (Stigma maydis) in healthcare: a phytochemical and pharmacological review. Molecules 2012;17:9697-715. View abstract.

George GO, Idu FK. Corn silk aqueous extracts and intraocular pressure of systemic and non-systemic hypertensive subjects. Clin Exp Optom. 2015 Mar;98(2):138-49. View abstract.

Li CC, Lee YC, Lo HY, Huang YW, Hsiang CY, Ho TY. Antihypertensive effects of corn silk extract and its novel bioactive constituent in spontaneously hypertensive rats: The involvement of angiotensin-converting enzyme inhibition. Molecules. 2019;24(10):1886. View abstract.

Kim YH, Cho A, Kwon SA, et al. Potential photoprotective effect of dietary corn silk extract on ultraviolet B-induced skin damage. Molecules. 2019;24(14):2587. View abstract.

Ikpeazu VO, Ugbogu EA, Emmanuel O, Uche-Ikonne C, Okoro B, Nnaemeka J. Evaluation of the safety of oral intake of aqueous extract of Stigma maydis (corn silk) in rats. Acta Sci Pol Technol Aliment. 2018;17(4):387-397. View abstract.

Shi S, Yu B, Li W, Shan J, Ma T. Corn silk decoction for blood lipid in patients with angina pectoris: A systematic review and meta-analysis. Phytother Res. 2019;33(11):2862-2869. View abstract.

Sheng L, Chen Q, Di L, Li N. Evaluation of anti-diabetic potential of corn silk in high-fat diet/streptozotocin- induced type 2 diabetes mice model. Endocr Metab Immune Disord Drug Targets. 2020. View abstract.